United States Pharmaceuticals

Track

Invivyd Inc (IVVD)

Track

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: IVVD Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Allen Robert D. III

Chief Scientific Officer

1 sale — total 30,597 USD

Planned sale 18 Feb 2026

Value US$1,647,722.93 | Price 371.24 | Shares 90,507

Green Julie

Chief Human Resources Officer

1 sale — total 33,077 USD

Planned sale 18 Feb 2026

Value US$1,132,368.82 | Price 155.24 | Shares 42,154

Duke William E.

Chief Financial Officer

1 sale — total 33,077 USD

Planned sale 18 Feb 2026

Value US$33,077.00 | Price 1.58 | Shares 20,964

Lee Timothy Edward

Chief Commercial Officer

1 sale — total 33,077 USD

Planned sale 18 Feb 2026

Value US$33,077.00 | Price 1.58 | Shares 20,964

Andersen Jill

Chief Legal Officer, Secretary

1 sale — total 55,127 USD

Planned sale 18 Feb 2026

Value US$55,126.75 | Price 1.58 | Shares 34,939

Allen Robert D. III

Chief Scientific Officer

2 sales — total 85,147 USD

Planned sale 17 Feb 2026

Value US$28,003.78 | Price 1.54 | Shares 18,189

Proposed sale 17 Feb 2026

Value US$57,142.80 | Price 1.56 | Shares 36,630

Green Julie

Chief Human Resources Officer

2 sales — total 92,049 USD

Planned sale 17 Feb 2026

Value US$30,273.15 | Price 1.54 | Shares 19,663

Proposed sale 17 Feb 2026

Value US$61,776.00 | Price 1.56 | Shares 39,600

Duke William E.

Chief Financial Officer

2 sales — total 92,049 USD

Planned sale 17 Feb 2026

Value US$30,273.15 | Price 1.54 | Shares 19,663

Proposed sale 17 Feb 2026

Value US$61,776.00 | Price 1.56 | Shares 39,600

Lee Timothy Edward

Chief Commercial Officer

2 sales — total 92,049 USD

Planned sale 17 Feb 2026

Value US$30,273.15 | Price 1.54 | Shares 19,663

Proposed sale 17 Feb 2026

Value US$61,776.00 | Price 1.56 | Shares 39,600

Andersen Jill

Chief Legal Officer, Secretary

2 sales — total 153,414 USD

Planned sale 17 Feb 2026

Value US$50,454.23 | Price 1.54 | Shares 32,771

Proposed sale 17 Feb 2026

Value US$102,960.00 | Price 1.56 | Shares 66,000

ADIMAB, LLC

10% Stockholder

1 sale — total 577,499 USD

Proposed sale 23 Dec 2025

Value US$577,498.50 | Price 3.00 | Shares 192,320

MCLAUGHLIN KEVIN F

1 purchase — total 125,000 USD

Buy 19 Nov 2025

Value US$125,000.00 | Price 2.50 | Shares 50,000

ADIMAB, LLC

10% Stockholder

1 sale — total 3,703,455 USD

Proposed sale 17 Nov 2025

Value US$3,703,454.88 | Price 3.00 | Shares 1,233,416

Duke William E.

Chief Financial Officer

1 sale — total 16,796 USD

Planned sale 19 Aug 2025

Value US$16,795.72 | Price 0.57 | Shares 29,643

Andersen Jill

Chief Legal Officer, Secretary

1 sale — total 27,991 USD

Planned sale 19 Aug 2025

Value US$27,991.17 | Price 0.57 | Shares 49,402

Allen Robert D. III

Chief Scientific Officer

1 sale — total 15,536 USD

Planned sale 19 Aug 2025

Value US$15,536.17 | Price 0.57 | Shares 27,420

Lee Timothy Edward

Chief Commercial Officer

1 sale — total 16,796 USD

Planned sale 19 Aug 2025

Value US$16,795.72 | Price 0.57 | Shares 29,643

Green Julie

Chief Human Resources Officer

1 sale — total 16,796 USD

Planned sale 19 Aug 2025

Value US$16,795.72 | Price 0.57 | Shares 29,643

Duke William E.

Chief Financial Officer

2 sales — total 41,014 USD

Planned sale 18 Aug 2025

Value US$13,012.45 | Price 0.65 | Shares 20,013

Proposed sale 18 Aug 2025

Value US$28,001.87 | Price 0.71 | Shares 39,601

Andersen Jill

Chief Legal Officer, Secretary

2 sales — total 68,354 USD

Planned sale 18 Aug 2025

Value US$21,685.47 | Price 0.65 | Shares 33,352

Proposed sale 18 Aug 2025

Value US$46,668.60 | Price 0.71 | Shares 66,000

Allen Robert D. III

Chief Scientific Officer

2 sales — total 37,938 USD

Planned sale 18 Aug 2025

Value US$12,036.50 | Price 0.65 | Shares 18,512

Proposed sale 18 Aug 2025

Value US$25,901.78 | Price 0.71 | Shares 36,631

Lee Timothy Edward

Chief Commercial Officer

2 sales — total 41,014 USD

Planned sale 18 Aug 2025

Value US$13,012.45 | Price 0.65 | Shares 20,013

Proposed sale 18 Aug 2025

Value US$28,001.16 | Price 0.71 | Shares 39,600

Green Julie

Chief Human Resources Officer

2 sales — total 41,014 USD

Planned sale 18 Aug 2025

Value US$13,012.45 | Price 0.65 | Shares 20,013

Proposed sale 18 Aug 2025

Value US$28,001.16 | Price 0.71 | Shares 39,600

MCGUIRE TERRANCE

1 sale — total 46,098 USD

Sale 31 Dec 2024

Value US$46,097.67 | Price 0.45 | Shares 103,474

MCGUIRE TERRANCE

1 sale — total 41,784 USD

Sale 30 Dec 2024

Value US$41,783.93 | Price 0.48 | Shares 86,545

MCGUIRE TERRANCE

1 sale — total 43,647 USD

Sale 27 Dec 2024

Value US$43,647.37 | Price 0.52 | Shares 83,744

MCGUIRE TERRANCE

1 sale — total 45,563 USD

Sale 26 Dec 2024

Value US$45,562.92 | Price 0.54 | Shares 83,817

MCGUIRE TERRANCE

1 sale — total 34,503 USD

Sale 24 Dec 2024

Value US$34,503.10 | Price 0.51 | Shares 68,161

MCGUIRE TERRANCE

1 sale — total 34,076 USD

Sale 23 Dec 2024

Value US$34,076.47 | Price 0.45 | Shares 75,776

MCGUIRE TERRANCE

1 sale — total 50,725 USD

Sale 20 Dec 2024

Value US$50,725.44 | Price 0.42 | Shares 119,805

POLARIS PARTNERS IX, LP

Director

1 sale — total 443,900 USD

Proposed sale 20 Dec 2024

Value US$443,900.00 | Price 0.44 | Shares 1,000,000

MCGUIRE TERRANCE

1 sale — total 65,951 USD

Sale 19 Dec 2024

Value US$65,951.46 | Price 0.43 | Shares 152,067

MCGUIRE TERRANCE

1 sale — total 35,087 USD

Sale 18 Dec 2024

Value US$35,086.75 | Price 0.47 | Shares 74,764

MCGUIRE TERRANCE

1 sale — total 46,757 USD

Sale 17 Dec 2024

Value US$46,756.80 | Price 0.48 | Shares 97,410

MCGUIRE TERRANCE

1 sale — total 30,510 USD

Sale 16 Dec 2024

Value US$30,509.58 | Price 0.47 | Shares 65,359

MCGUIRE TERRANCE

1 sale — total 72,875 USD

Sale 12 Dec 2024

Value US$72,875.00 | Price 0.58 | Shares 125,000

MCGUIRE TERRANCE

1 sale — total 94,812 USD

Sale 11 Dec 2024

Value US$94,812.44 | Price 0.59 | Shares 160,400

MCGUIRE TERRANCE

1 sale — total 103,005 USD

Sale 10 Dec 2024

Value US$103,005.00 | Price 0.59 | Shares 175,000

MCGUIRE TERRANCE

1 sale — total 91,560 USD

Sale 9 Dec 2024

Value US$91,560.00 | Price 0.61 | Shares 150,000

POLARIS PARTNERS IX, LP

Director

1 sale — total 610,400 USD

Proposed sale 9 Dec 2024

Value US$610,400.00 | Price 0.61 | Shares 1,000,000

MCGUIRE TERRANCE

1 sale — total 186,575 USD

Sale 29 May 2024

Value US$186,574.94 | Price 1.66 | Shares 112,381

Polaris Partners IX, L.P.

Director

1 sale — total 186,575 USD

Proposed sale 29 May 2024

Value US$186,574.94 | Price 0.19 | Shares 1,000,000

DAVID NEIL HERING

Officer

1 sale — total 24,339 USD

Proposed sale 16 May 2024

Value US$24,339.00 | Price 2.43 | Shares 10,000

Adimab, LLC

1 sale — total 19,750,000 USD

Sale 19 Jan 2024

Value US$19,750,000.00 | Price 3.95 | Shares 5,000,000

ADIMAB, LLC

10% Stockholder

1 sale — total 19,750,000 USD

Proposed sale 19 Jan 2024

Value US$19,750,000.00 | Price 3.95 | Shares 5,000,000

Hering David

Chief Executive Officer

1 purchase — total 36,160 USD

Buy 1 Sep 2022

Value US$36,160.00 | Price 4.52 | Shares 8,000

Elia Marc

See Footnote 5

1 purchase — total 2,700,164 USD

Buy 19 Aug 2022

Value US$2,700,163.62 | Price 4.62 | Shares 584,451

Elia Marc

See Footnote 5

1 purchase — total 5,454,516 USD

Buy 18 Aug 2022

Value US$5,454,516.19 | Price 4.31 | Shares 1,265,549

Elia Marc

See Footnote 5

1 purchase — total 4,040,000 USD

Buy 17 Aug 2022

Value US$4,040,000.00 | Price 4.04 | Shares 1,000,000

Royan Ajay

1 purchase — total 33,949,000 USD

Buy 10 Aug 2021

Value US$33,949,000.00 | Price 17.00 | Shares 1,997,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-02-18	2026-02-18	PlS Planned sale	Allen Robert D. III Chief Scientific Officer Officer	90,507 +4.4% 371.24 US$1,647,723	90,507 +4.4%	371.24	US$1,647,723
2026-02-18	2026-02-18	PlS Planned sale	Green Julie Chief Human Resources Officer Officer	42,154 +27.9% 155.24 US$1,132,369	42,154 +27.9%	155.24	US$1,132,369
2026-02-18	2026-02-18	PlS Planned sale	Duke William E. Chief Financial Officer Officer	38,854 +46.7% 101.43 US$1,804,696	38,854 +46.7%	101.43	US$1,804,696
2026-02-18	2026-02-18	PlS Planned sale	Lee Timothy Edward Chief Commercial Officer Officer	20,964 -15.1% 1.58 US$33,077	20,964 -15.1%	1.58	US$33,077
2026-02-18	2026-02-18	PlS Planned sale	Andersen Jill Chief Legal Officer, Secretary Officer	34,939 -16.1% 1.58 US$55,127	34,939 -16.1%	1.58	US$55,127
2026-02-18	2026-02-17	PlS Planned sale	Allen Robert D. III Chief Scientific Officer Officer	18,189 -12.0% 1.54 US$28,004	18,189 -12.0%	1.54	US$28,004
2026-02-18	2026-02-17	PlS Planned sale	Green Julie Chief Human Resources Officer Officer	19,663 -13.3% 1.54 US$30,273	19,663 -13.3%	1.54	US$30,273
2026-02-18	2026-02-17	PlS Planned sale	Duke William E. Chief Financial Officer Officer	19,663 -13.3% 1.54 US$30,273	19,663 -13.3%	1.54	US$30,273
2026-02-18	2026-02-17	PlS Planned sale	Lee Timothy Edward Chief Commercial Officer Officer	19,663 -12.4% 1.54 US$30,273	19,663 -12.4%	1.54	US$30,273
2026-02-18	2026-02-17	PlS Planned sale	Andersen Jill Chief Legal Officer, Secretary Officer	32,771 -13.1% 1.54 US$50,454	32,771 -13.1%	1.54	US$50,454
2026-02-17	2026-02-17	PrS Proposed sale	Green Julie Officer Officer	39,600 1.56 US$61,776	39,600	1.56	US$61,776
2026-02-17	2026-02-17	PrS Proposed sale	Allen Robert D. III Officer Officer	36,630 1.56 US$57,143	36,630	1.56	US$57,143
2026-02-17	2026-02-17	PrS Proposed sale	Lee Timothy Edward Officer Officer	39,600 1.56 US$61,776	39,600	1.56	US$61,776
2026-02-17	2026-02-17	PrS Proposed sale	Duke William E. Officer Officer	39,600 1.56 US$61,776	39,600	1.56	US$61,776
2026-02-17	2026-02-17	PrS Proposed sale	Andersen Jill Officer Officer	66,000 1.56 US$102,960	66,000	1.56	US$102,960
2025-12-23	2025-12-23	PrS Proposed sale	ADIMAB, LLC 10% Stockholder Large shareholder	192,320 3.00 US$577,498	192,320	3.00	US$577,498
2025-11-20	2025-11-19	B Purchase	0.6 MCLAUGHLIN KEVIN F Non-Executive Director	50,000 +inf% 2.50 US$125,000	50,000 +inf%	2.50	US$125,000
2025-11-17	2025-11-17	PrS Proposed sale	ADIMAB, LLC 10% Stockholder Large shareholder	1,233,416 3.00 US$3,703,455	1,233,416	3.00	US$3,703,455
2025-08-19	2025-08-19	PlS Planned sale	Duke William E. Chief Financial Officer Officer	29,643 -37.5% 0.57 US$16,796	29,643 -37.5%	0.57	US$16,796
2025-08-19	2025-08-19	PlS Planned sale	Andersen Jill Chief Legal Officer, Secretary Officer	49,402 -36.9% 0.57 US$27,991	49,402 -36.9%	0.57	US$27,991
2025-08-19	2025-08-19	PlS Planned sale	Allen Robert D. III Chief Scientific Officer Officer	27,420 -34.1% 0.57 US$15,536	27,420 -34.1%	0.57	US$15,536
2025-08-19	2025-08-19	PlS Planned sale	Lee Timothy Edward Chief Commercial Officer Officer	29,643 -33.3% 0.57 US$16,796	29,643 -33.3%	0.57	US$16,796
2025-08-19	2025-08-19	PlS Planned sale	Green Julie Chief Human Resources Officer Officer	29,643 -37.5% 0.57 US$16,796	29,643 -37.5%	0.57	US$16,796
2025-08-19	2025-08-18	PlS Planned sale	Duke William E. Chief Financial Officer Officer	20,013 -20.2% 0.65 US$13,012	20,013 -20.2%	0.65	US$13,012
2025-08-19	2025-08-18	PlS Planned sale	Andersen Jill Chief Legal Officer, Secretary Officer	33,352 -19.9% 0.65 US$21,685	33,352 -19.9%	0.65	US$21,685
2025-08-19	2025-08-18	PlS Planned sale	Allen Robert D. III Chief Scientific Officer Officer	18,512 -18.7% 0.65 US$12,037	18,512 -18.7%	0.65	US$12,037
2025-08-19	2025-08-18	PlS Planned sale	Lee Timothy Edward Chief Commercial Officer Officer	20,013 -18.4% 0.65 US$13,012	20,013 -18.4%	0.65	US$13,012
2025-08-19	2025-08-18	PlS Planned sale	Green Julie Chief Human Resources Officer Officer	20,013 -20.2% 0.65 US$13,012	20,013 -20.2%	0.65	US$13,012
2025-08-18	2025-08-18	PrS Proposed sale	Green Julie Officer Officer	39,600 0.71 US$28,001	39,600	0.71	US$28,001
2025-08-18	2025-08-18	PrS Proposed sale	Andersen Jill Officer Officer	66,000 0.71 US$46,669	66,000	0.71	US$46,669
2025-08-18	2025-08-18	PrS Proposed sale	Allen Robert D. III Officer Officer	36,631 0.71 US$25,902	36,631	0.71	US$25,902
2025-08-18	2025-08-18	PrS Proposed sale	Lee Timothy Edward Officer Officer	39,600 0.71 US$28,001	39,600	0.71	US$28,001
2025-08-18	2025-08-18	PrS Proposed sale	Duke William E. Officer Officer	39,601 0.71 US$28,002	39,601	0.71	US$28,002
2024-12-31	2024-12-31	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	103,474 -3.3% 0.45 US$46,098	103,474 -3.3%	0.45	US$46,098
2024-12-31	2024-12-30	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	86,545 -2.7% 0.48 US$41,784	86,545 -2.7%	0.48	US$41,784
2024-12-31	2024-12-27	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	83,744 -2.5% 0.52 US$43,647	83,744 -2.5%	0.52	US$43,647
2024-12-26	2024-12-26	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	83,817 -2.4% 0.54 US$45,563	83,817 -2.4%	0.54	US$45,563
2024-12-26	2024-12-24	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	68,161 -2.0% 0.51 US$34,503	68,161 -2.0%	0.51	US$34,503
2024-12-26	2024-12-23	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	75,776 -2.1% 0.45 US$34,076	75,776 -2.1%	0.45	US$34,076
2024-12-26	2024-12-20	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	119,805 -3.2% 0.42 US$50,725	119,805 -3.2%	0.42	US$50,725
2024-12-20	2024-12-20	PrS Proposed sale	POLARIS PARTNERS IX, LP Director Non-Executive Director	1,000,000 0.44 US$443,900	1,000,000	0.44	US$443,900
2024-12-19	2024-12-19	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	152,067 -4.0% 0.43 US$65,951	152,067 -4.0%	0.43	US$65,951
2024-12-19	2024-12-18	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	74,764 -1.9% 0.47 US$35,087	74,764 -1.9%	0.47	US$35,087
2024-12-19	2024-12-17	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	97,410 -2.4% 0.48 US$46,757	97,410 -2.4%	0.48	US$46,757
2024-12-16	2024-12-16	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	65,359 -1.6% 0.47 US$30,510	65,359 -1.6%	0.47	US$30,510
2024-12-16	2024-12-12	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	125,000 -3.0% 0.58 US$72,875	125,000 -3.0%	0.58	US$72,875
2024-12-11	2024-12-11	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	160,400 -3.7% 0.59 US$94,812	160,400 -3.7%	0.59	US$94,812
2024-12-11	2024-12-10	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	175,000 -3.9% 0.59 US$103,005	175,000 -3.9%	0.59	US$103,005
2024-12-11	2024-12-09	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	150,000 -3.2% 0.61 US$91,560	150,000 -3.2%	0.61	US$91,560
2024-12-09	2024-12-09	PrS Proposed sale	POLARIS PARTNERS IX, LP Director Non-Executive Director	1,000,000 0.61 US$610,400	1,000,000	0.61	US$610,400
2024-05-31	2024-05-29	S Sale	1.4 MCGUIRE TERRANCE Non-Executive Director	112,381 -2.3% 1.66 US$186,575	112,381 -2.3%	1.66	US$186,575
2024-05-29	2024-05-29	PrS Proposed sale	Polaris Partners IX, L.P. Director Non-Executive Director	1,000,000 0.19 US$186,575	1,000,000	0.19	US$186,575
2024-05-16	2024-05-16	PrS Proposed sale	0.5 DAVID NEIL HERING Officer Officer	10,000 2.43 US$24,339	10,000	2.43	US$24,339
2024-01-22	2024-01-19	S Sale	Adimab, LLC Large shareholder	5,000,000 -18.7% 3.95 US$19,750,000	5,000,000 -18.7%	3.95	US$19,750,000
2024-01-19	2024-01-19	PrS Proposed sale	ADIMAB, LLC 10% Stockholder Large shareholder	5,000,000 3.95 US$19,750,000	5,000,000	3.95	US$19,750,000
2022-09-01	2022-09-01	B Purchase	0.5 Hering David Chief Executive Officer Executive Director	8,000 +inf% 4.52 US$36,160	8,000 +inf%	4.52	US$36,160
2022-08-19	2022-08-19	B Purchase	0.9 Elia Marc See Footnote 5 Non-Executive Director	584,451 +6.7% 4.62 US$2,700,164	584,451 +6.7%	4.62	US$2,700,164
2022-08-19	2022-08-18	B Purchase	0.9 Elia Marc See Footnote 5 Non-Executive Director	1,265,549 +17.1% 4.31 US$5,454,516	1,265,549 +17.1%	4.31	US$5,454,516
2022-08-19	2022-08-17	B Purchase	0.9 Elia Marc See Footnote 5 Non-Executive Director	1,000,000 +15.6% 4.04 US$4,040,000	1,000,000 +15.6%	4.04	US$4,040,000
2021-08-12	2021-08-10	B Purchase	2.3 Royan Ajay Non-Executive Director Large shareholder	1,997,000 +21.6% 17.00 US$33,949,000	1,997,000 +21.6%	17.00	US$33,949,000

Explore more

More insider trading research around Invivyd Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Pharmaceuticals companies with insider activity

Insider trading in North America

Invivyd Inc (IVVD)

Track

Featured in screeners

Stock chart

Transactions

Insider

Sort by

Trades

Explore more